Self controlled dose of Thyrax and QoL in patients with hypothyroidism.

The effect of a self controlled dose of Levothyroxine on the quality of life and thyroid stimulating hormone in patients treated for hypothyroidism: A randomized, double blind, consecutive study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29339

Enrollment

100

Registered

2011-03-11

Start date

2011-06-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self-controlled dose Levothyroxine Quality of life Hypothyroidism Zelf-gecontroleerde dosis Levothyroxine Kwaliteit van leven Hypothyreoidie

Interventions

Patients who are not content about the treatment of their hypothyroidism with Levothyroxine get the chance to controle their own dose. There will be 2 moments during the study where they can decide if

Eligibility

Inclusion criteria

Inclusion criteria: 1. Primary Hypothyroidism; 2. Euthyroidism; 3. Stable dose of Levothyroxine for over 6 months; 4. Age 18-75; 5. Own wish to change dose of medication.

Exclusion criteria

Exclusion criteria: Pregnancy.

Design outcomes

Primary

Measure	Time frame
1. QoL by SF/RAND 36; 2. Symptoms and complaints by symptomlist hypothyroidism; 3. General symptom list and Hospital anxiety and depression scale; 4. TSH,T4 and T3.	—

Secondary

Measure	Time frame
1. Influence of BMI on QoL; 2. Clinical parameters like heartbeat, blood pressure and laboratory findings.	—

Contacts

Public ContactC. Zevenbergen

Tomatenplein 27

ZevenbergenC@maasstadziekenhuis.nl+31 (0)10 2912716

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)